Selskabets formål er forskning og udvikling af lægemidler samt dermed beslægtet virksomhed.
| Year | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2024 | -30.6 mio. | -32.3 mio. | 225.4 mio. | 201.2 mio. | 2 | |
CVR: 38402056
Previous names: Antag Therapeutics IVS
Compared to 131 companies in Fremstilling af farmaceutiske præparater
Comparison is based on industry median values
Jørgen Søberg Petersen joined the board
Novo Holdings A/S registered with 20% ownership
registered with 5% ownership
registered with 25% ownership
registered with 10% ownership
Jørgen Søberg Petersen left the board
Jörg Möller left the board
Philip Just Larsen joined as ADM. DIR.
Jörg Möller left as ADM. DIR.
Companies in the same industry and area
CVR 39859173
CVR 39880377
CVR 42057428
CVR 43432583
CVR 43575627
companydata.dk